Ad
related to: should i sell merck stock symbol
Search results
Results from the WOW.Com Content Network
There is plenty to like about Merck (NYSE: MRK). It is one of the largest pharmaceutical companies and the owner of the world's current best-selling drug, cancer medicine Keytruda. Merck generates ...
The next few years might get bumpy for the pharmaceutical giant, but the longer term looks better.
Even with that growth, the stock still trades at a fairly modest valuation. Its stock price is up 5.3% this year, compared with 16% growth for the S&P 500. Why isn't Merck's stock doing better in ...
Keytruda has been the best-selling medicine in the world since last year, when it generated $25 billion in sales. Merck's total revenue for the year was $60.1 billion, so Keytruda accounted for ...
Merck (NYSE: MRK) is no exception. What Merck may lack in raw growth firepower, however, it makes up for with savvy portfolio management. Take its best-selling drug Keytruda as an example.
In terms of valuation, Merck stock is trading at a forward price-to-earnings (P/E) ratio of 14, which is near a peer-group average of 15 among pharmaceutical leaders like Johnson & Johnson, Pfizer ...
For premium support please call: 800-290-4726 more ways to reach us
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Cumulatively, through this week, it has been a 122% ...
Ad
related to: should i sell merck stock symbol